A Practical Approach to Genetic Testing for von Willebrand Disease

Pruthi, Rajiv K.
May 2006
Mayo Clinic Proceedings;May2006, Vol. 81 Issue 5, p679
Academic Journal
von Willebrand disease (vWD) is the most commonly diagnosed congenital bleeding disorder. The laboratory diagnosis of type 2 variants and type 3 vWD is reasonably well defined, and characterization of the von Willebrand factor (vWF) gene has facilitated definition of their molecular basis. However, for type 1 vWD, the laboratory diagnosis poses a diagnostic dilemma, and knowledge of its molecular basis is evolving. Characterization of the vWF gene and refinement of genetic techniques have led to an evolving repertoire of genetic tests. Genetic testing is costly, and thus judicious use will be increasingly important for appropriate genetic counseilng of patients with vWD and their family members. This article provides a practical approach to utilization of genetic testing In vWD.


Related Articles

  • A 62-year-old woman with increased bleeding tendency. Varadarajan, Ramya // Hem/Onc Today;11/10/2009, Vol. 10 Issue 21, p12 

    This case report focuses on a 62-year-old white woman who suffered from vaginal bleeding and was advised to use von Willebrand factor replacement therapy.

  • Diagnosis and Management of Von Willebrand Disease: Guidelines for Primary Care. YAWN, BARBARA P.; NICHOLS, WILLIAM L.; RICK, MARGARET E. // American Family Physician;12/1/2009, Vol. 80 Issue 11, p1261 

    Von Willebrand disease is an inherited condition characterized by deficiency of von Willebrand factor, which is essential in hemostasis. The National Heart, Lung, and Blood Institute has released new evidence-based guidelines for the diagnosis and management of the disease. There are three major...

  • First of its kind guide released for bleeding disorder. Belden, Heidi // Drug Topics;7/14/2008, Vol. 152 Issue 8, p16 

    The article reports on the guidelines for diagnosis and management of von Willebrand disease (VWD) issued by the U.S. National Heart, Lung, and Blood Institute. The guide states that the goal to treat VWD is to stop bleeding or to provide prophylaxis for surgical procedures. It also notes that...

  • Gastrointestinal Bleeding Following LVAD Placement from Top to Bottom. Cushing, Kelly; Kushnir, Vladimir // Digestive Diseases & Sciences;Jun2016, Vol. 61 Issue 6, p1440 

    Background: Left ventricular assist devices (LVADs) are an increasingly prevalent form of mechanical support for patients with end-stage heart failure. These devices can be implanted both as a bridge to transplant and as definitive/destination therapy. Gastrointestinal (GI) bleeding...

  • Moschcowitz, Multimers, and Metalloprotease. Moake, Joel L. // New England Journal of Medicine;11/26/98, Vol. 339 Issue 22, p1629 

    Editorial. Discusses the causes of thrombotic thrombocytopenic purpura. Case described by Eli Moschcowitz in 1924; Presence of large multimers of von Willebrand factor in patients with the disease; Mechanism of von Willebrand factor processing identified; Research in this issue by Furlan et al,...

  • Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis and Low Cardiovascular Risk: The Role of von Willebrand Factor Activity. Ristić, Gorica G.; Subota, Vesna; Lepić, Toplica; Stanisavljević, Dejana; Glišić, Branislava; Ristić, Arsen D.; Petronijević, Milan; Stefanović, Dušan Z. // PLoS ONE;8/6/2015, Vol. 10 Issue 8, p1 

    Background: To evaluate association between von Willebrand factor (vWF) activity, inflammation markers, disease activity, and subclinical atherosclerosis in patients with rheumatoid arthritis (RA) and low cardiovascular risk. Methods: Above mentioned parameters were determined in blood samples...

  • 1-Desamino-8-D-arginine Vasopressin (Desmopressin) Shortens the Bleeding Time in Storage Pool Deficiency. Nieuwenhuis, H. Karel; Sixma, Jan J. // Annals of Internal Medicine;Jan88, Vol. 108 Issue 1, p65 

    Deals with a study which determined whether desmopressin is effective in patients with storage pool deficiency. Characteristics of the bleeding tendency of patients with congenital or acquired storage pool deficiency; Practice that would correct the bleeding abnormalities; Result of an enhanced...

  • Determination of von Willebrand Factor Activity: Evaluation of the HaemosIL Assay in Comparison With Established Procedures. Sucker, Christopher; Senft, Beate; Scharf, Rüdiger E.; Zotz, Rainer B. // Clinical & Applied Thrombosis/Hemostasis;Jul2006, Vol. 12 Issue 3, p305 

    Determination of yon Willebrand factor activity is required for diagnosis and classification of yon Willebrand disease. In addition, yon Willebrand factor activity can be of prognostic relevance in several clinical entities including thromboembolic and cardiovascular disorders in which elevated...

  • Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease. Castaman, Giancarlo // Mediterranean Journal of Hematology & Infectious Diseases;2013, Vol. 5 Issue 1, p1 

    Delivery in von Willebrand disease (VWD) represents a significant hemostatic challenge because of the variable pattern of changes observed during pregnancy of von Willebrand factor (VWF) and factor VIII (FVIII), the protein carried by VWF. Since a wide heterogeneity of phenotypes and of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics